Search Within

Raymond P Warrell

Formats
  1. Journal Article (97)
  2. Meeting Abstract (68)
  3. Conference Paper (7)
  4. Book Section (3)
Groups
  1. Department of Medicine (56)
  2. Center for Hematologic Malignancies (42)
  3. Hematologic Malignancies, Division of (42)
  4. Adult Leukemia (33)
  5. Sloan Kettering Institute Faculty (25)
  6. Tow Center for Developmental Oncology (TCDO) (25)

More Groups

People
  1. Pier Pandolfi Derinaldis (28)
  2. Steven Soignet (25)
  3. David Scheinberg (24)
  4. Wilson Miller (20)
  5. Vincent Miller (19)
  6. William Tong (18)

More People

Years
  1. 2006 (2)
  2. 2004 (1)
  3. 2002 (1)
  4. 2001 (4)
  5. 2000 (11)
  6. 1999 (11)

More Years

Publications
  1. Blood (50)
  2. Journal of Clinical Oncology (12)
  3. Proceedings of the American Association for Cancer Research Annual Meeting (12)
  4. Leukemia (11)
  5. Clinical Research (8)
  6. New England Journal of Medicine (8)

More Publications

Publishers
  1. American Society of Hematology (50)
  2. American Association for Cancer Research (22)
  3. American Society of Clinical Oncology (12)
  4. Nature Publishing Group (11)
  5. Massachusetts Medical Society (8)
  6. SLACK, Inc. (8)

More Publishers

Results (175)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pilot study of combination transcriptional modulation therapy with sodium phenylbutyrate and 5-azacytidine in patients with acute myeloid leukemia or myelodysplastic syndrome
    Journal Article

    Maslak, P.; Chanel, S.; Camacho, L. H.; Soignet, S.; Pandolfi, P. P.; Guernah, I.; Warrell, R.; Nimer, S.
    Leukemia (2006)

    Fulltext@MSK | Save
  • Randomized, double-blind, phase II trial of gallium nitrate compared with pamidronate for acute control of cancer-related hypercalcemia
    Journal Article

    Cvitkovic, F.; Armand, J. P.; Tubiana-Hulin, M.; Rossi, J. F.; Warrell, R. P. Jr
    The Cancer Journal (2006)

    Fulltext@MSK | Save
  • Acute promyelocytic leukemia cell line AP-1060 established as a cytokine-dependent culture from a patient clinically resistant to all-trans retinoic acid and arsenic trioxide
    Journal Article

    Sun, Y.; Kim, S. H.; Zhou, D. C.; Ding, W.; Paietta, E.; Guidez, F.; Zelent, A.; Ramesh, K. H.; Cannizzaro, L.; Warrell, R. P. Jr; more...
    Leukemia (2004)

    Fulltext@MSK | Save
  • Frequent mutations in the ligand-binding domain of PML-RARα after multiple relapses of acute promyelocytic leukemia: Analysis for functional relationship to response to all-trans retinoic acid and histone deacetylase inhibitors in vitro and in vivo
    Journal Article

    Zhou, D.; Kim, S. H.; Ding, W.; Schultz, C.; Warrell, R. P. Jr; Gallagher, R. E.
    Blood (2002)

    Fulltext@MSK | Save
  • Immortalization of acute promyelocytic leukemia (APL) cell culture AP-1060 associated with altered growth factor response
    Meeting Abstract

    Sun, Y.; Kim, S. H.; Ramesh, K. H.; Cannizzaro, L.; Paietta, E.; Warrell, R. P.; Gallagher, R. E.
    Blood (2001)

    Fulltext@MSK | Save
  • United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia
    Journal Article

    Soignet, S. L.; Frankel, S. R.; Douer, D.; Tallman, M. S.; Kantarjian, H.; Calleja, E.; Stone, R. M.; Kalaycio, M.; Scheinberg, D. A.; Steinherz, P.; more...
    Journal of Clinical Oncology (2001)

    Fulltext@MSK | Save
  • Histone deacetylase inhibitors induce remission in transgenic models of therapy-resistant acute promyelocytic leukemia
    Journal Article

    He, L. Z.; Tolentino, T.; Grayson, P.; Zhong, S.; Warrell, R. P. Jr; Rifkind, R. A.; Marks, P. A.; Richon, V. M.; Pandolfi, P. P.
    Journal of Clinical Investigation (2001)

    Fulltext@MSK | Save
  • Prognostic significance of minimal residual disease detection and PML/RAR-α isoform type: Long-term follow-up in acute promyelocytic leukemia
    Journal Article

    Jurcic, J. G.; Nimer, S. D.; Scheinberg, D. A.; Deblasio, T.; Warrell, R. P. Jr; Miller, W. H. Jr
    Blood (2001)

    Fulltext@MSK | Save
  • Arsenic trioxide (As(2)O(3)): A dose-ranging and clinical pharmacologic study in patients with advanced hematologic cancers
    Meeting Abstract

    Soignet, S. L.; Novick, S.; Bienvenu, B.; Chanel, S.; Ho, R.; Spriggs, D.; Ellison, R.; Warrell, R. P. Jr
    Proceedings of the American Association for Cancer Research Annual Meeting (2000)

    Fulltext@MSK | Save
  • Pharmacokinetics of arsenic trioxide (ATO) in patients with relapsed/refractory acute promyelocytic leukemia (APL)
    Meeting Abstract

    Soignet, S.; Bienvenu, B.; Warrell, R. P.; Ellisson, R.; Spriggs, D.; Brannan, M.
    Clinical Cancer Research (2000)

    Fulltext@MSK | Save